Brian Elsbernd is Chief Compliance/Legal Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 271,039 shares of CPRX, which is worth approximately $5.35 Million. The most recent transaction as insider was on Dec 06, 2022, when has been sold 14,667 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 271K
43.74% 3M change
117.82% 12M change
Total Value Held $5.35 Million

Brian Elsbernd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
14,667 Added 10.09%
130,763 Common Stock, par valu...
Nov 14 2022
BUY
Exercise of conversion of derivative security
$138,600 $1.32 p/Share
105,000 Added 47.49%
116,096 Common Stock, par valu...
Nov 11 2022
SELL
Open market or private sale
$238,029 $16.23 p/Share
14,666 Reduced 56.93%
11,096 Common Stock, par valu...
Dec 03 2021
SELL
Payment of exercise price or tax liability
-
3,571 Reduced 12.17%
25,762 Common Stock, par valu...
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
14,667 Added 33.33%
29,333 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
14,666 Added 50.0%
14,666 Common Stock, par valu...
BE

Brian Elsbernd

Chief Compliance/Legal Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX